VERTEX PHARMACEUTICALS

vertex-pharmaceuticals-logo

Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

#SimilarOrganizations #People #Financial #Event #Website #More

VERTEX PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
1989-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.vrtx.com

Total Employee:
1001+

Status:
Active

Contact:
617-341-6100

Email Addresses:
[email protected]

Total Funding:
657.31 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Content Delivery Network LetsEncrypt Font Awesome Mobile Non Scaleable Content


Similar Organizations

aveo-oncology-logo

AVEO Oncology

AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.

exelixis-logo

Exelixis

Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.

gt-biopharma-logo

GT Biopharma

GT Biopharma specializes in the research and development of therapeutic products used primarily for the treatment of cancer.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

ionis-pharmaceuticals-logo

Ionis Pharmaceuticals

Ionis Pharmaceuticals is a drugmaker company.

merck-logo

Merck

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

eyepoint-pharmaceuticals-logo

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.

synta-pharmaceuticals-logo

Synta Pharmaceuticals

Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

bausch-health-logo

Bausch Health

Bausch Health is a develops and markets medications used in the fields of neurology, dermatology and infectious diseases.


Current Advisors List

reshma-kewalramani_image

Reshma Kewalramani Board Member @ Vertex Pharmaceuticals
Board_member

not_available_image

Dennis Winger Member of the Board of Directors @ Vertex Pharmaceuticals
Board_member

not_available_image

Alan Garber Board Member @ Vertex Pharmaceuticals
Board_member

h-daniel-perez_image

H. Daniel Perez Advisory Board, Neurodegeneration @ Vertex Pharmaceuticals
Advisor
2010-01-01

matthew-emmens_image

Matthew Emmens Chairman of the Board of Director @ Vertex Pharmaceuticals
Board_member

lloyd-carney_image

Lloyd Carney Board Member @ Vertex Pharmaceuticals
Board_member
2019-02-01

yuchun-lee_image

Yuchun Lee Member of the Board of Directors @ Vertex Pharmaceuticals
Board_member
2012-09-01

elaine-ullian_image

Elaine Ullian Member of the Board of Directors @ Vertex Pharmaceuticals
Board_member
1997-01-01

Current Employees Featured

reshma-kewalramani_image

Reshma Kewalramani
Reshma Kewalramani President and Chief Executive Officer @ Vertex Pharmaceuticals
President and Chief Executive Officer
2020-04-01

jeffrey-leiden_image

Jeffrey Leiden
Jeffrey Leiden Executive Chairman @ Vertex Pharmaceuticals
Executive Chairman
2020-04-01

nina-devlin_image

Nina Devlin
Nina Devlin Senior Vice President and Chief Communications Officer @ Vertex Pharmaceuticals
Senior Vice President and Chief Communications Officer
2019-01-01

ludovic-fenaux_image

Ludovic Fenaux
Ludovic Fenaux Senior Vice President, International Commercial Operations @ Vertex Pharmaceuticals
Senior Vice President, International Commercial Operations

megan-krench_image

Megan Krench
Megan Krench Director of BD - External Innovation @ Vertex Pharmaceuticals
Director of BD - External Innovation
2020-02-01

brian-goldman_image

Brian Goldman
Brian Goldman Research Fellow @ Vertex Pharmaceuticals
Research Fellow

mark-hollison_image

Mark Hollison
Mark Hollison Procurement and Strategic Sourcing Director @ Vertex Pharmaceuticals
Procurement and Strategic Sourcing Director

john-gray_image

John Gray
John Gray Senior Vice President, Genetic Therapies Research @ Vertex Pharmaceuticals
Senior Vice President, Genetic Therapies Research

david-altshuler_image

David Altshuler
David Altshuler Executive Vice President, Global Research and Chief Scientific Officer @ Vertex Pharmaceuticals
Executive Vice President, Global Research and Chief Scientific Officer
2015-01-01

glenn-butcher_image

Glenn Butcher
Glenn Butcher Sr Director, Global Digital Marketing @ Vertex Pharmaceuticals
Sr Director, Global Digital Marketing
2016-02-01

Founder


joshua-boger_image

Joshua Boger

larry-bock_image

Larry Bock

Stock Details


Company's stock symbol is NASDAQ:VRTX

Acquisitions List

Date Company Article Price
2024-04-10 Alpine Immune Sciences Alpine Immune Sciences acquired by Vertex Pharmaceuticals 4.9 B USD
2023-09-12 Septerna Septerna acquired by Vertex Pharmaceuticals N/A
2022-07-11 ViaCyte ViaCyte acquired by Vertex Pharmaceuticals 320 M USD
2022-03-07 Vectrus Vectrus acquired by Vertex Pharmaceuticals 2.1 B USD
2019-09-03 Semma Therapeutics Semma Therapeutics acquired by Vertex Pharmaceuticals 950 M USD
2019-06-06 Exonics Therapeutics Exonics Therapeutics acquired by Vertex Pharmaceuticals 245 M USD
2009-03-12 ViroChem Pharma ViroChem Pharma acquired by Vertex Pharmaceuticals 400 M USD
2001-04-30 Aurora Biosciences Corporation Aurora Biosciences Corporation acquired by Vertex Pharmaceuticals N/A

Investors List

j-p-morgan-securities-inc_image

J.P. Morgan Securities Inc.

J.P. Morgan Securities Inc. investment in Post-IPO Equity - Vertex Pharmaceuticals

bank-of-america-merrill-lynch_image

Bank of America Merrill Lynch

Bank of America Merrill Lynch investment in Post-IPO Equity - Vertex Pharmaceuticals

morgan-stanley_image

Morgan Stanley

Morgan Stanley investment in Post-IPO Equity - Vertex Pharmaceuticals

goldman-sachs_image

Goldman Sachs

Goldman Sachs investment in Post-IPO Equity - Vertex Pharmaceuticals

janssen-pharmaceuticals_image

Janssen Belgium

Janssen Belgium investment in Post-IPO Equity - Vertex Pharmaceuticals

norwest-venture-partners_image

Norwest Venture Partners

Norwest Venture Partners investment in Venture Round - Vertex Pharmaceuticals

j-h--whitney---co_image

J.H. Whitney & Co

J.H. Whitney & Co investment in Venture Round - Vertex Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Venture Round - Vertex Pharmaceuticals

greylock_image

Greylock

Greylock investment in Venture Round - Vertex Pharmaceuticals

Investments List

Date Company Article Money raised
2021-11-09 Arbor Biotechnologies Vertex Pharmaceuticals investment in Series B - Arbor Biotechnologies 215 M USD
2020-03-12 Kymera Therapeutics Vertex Pharmaceuticals investment in Series C - Kymera Therapeutics 102 M USD
2018-12-09 Genomics Vertex Pharmaceuticals investment in Series B - Genomics 8 M EUR
2018-08-30 Genomics Vertex Pharmaceuticals investment in Series B - Genomics 25 M GBP
2017-12-06 Obsidian Therapeutics Vertex Pharmaceuticals investment in Series A - Obsidian Therapeutics 49.5 M USD
2015-04-30 CRISPR Therapeutics Vertex Pharmaceuticals investment in Series B - CRISPR Therapeutics 29 M USD

Newest Events participated

oncology-strategy-meeting-europe-2018_event_image Participated in Oncology Strategy Meeting Europe 2018 on 2018-05-22 as speaker

forbes-under-30-summit-2016_event_image Participated in Forbes Under 30 Summit 2016 on 2016-10-16 as sponsor

Official Site Inspections

http://www.vrtx.com Semrush global rank: 252.29 K Semrush visits lastest month: 163.15 K

  • Host name: 45.60.6.246
  • IP address: 45.60.6.246
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Vertex Pharmaceuticals"

Vertex Pharmaceuticals | Home

At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases. We’re focused on discovering, developing and producing innovative …See details»

Vertex Pharmaceuticals | Our Company

At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases with a focus on specialty markets. It’s not just about what we do, but how we do it.See details»

Vertex Pharmaceuticals | Our Company

Our headquarters are in Boston and London. We’re focused on discovering, developing and bringing innovative medicines to people with serious diseases so they can lead better lives.See details»

Vertex Pharmaceuticals | The Science of Possibility

At Vertex, we work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, …See details»

Vertex Pharmaceuticals - Wikipedia

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, EnglandSee details»

Our Commitment to Research | Vertex Pharmaceuticals - vrtx.ca

At Vertex, we are a science-led organization. Three out of five Vertex employees are dedicated to research and development (R&D) and we invest more of our operating expenses in R&D than …See details»

Vertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance

See the company profile for Vertex Pharmaceuticals Incorporated (VRTX) including business summary, industry/sector information, number of employees, business summary, corporate …See details»

Versatile Real-Time Executive - Wikipedia

Versatile Real-Time Executive (VRTX) is a real-time operating system (RTOS) developed and marketed by the company Mentor Graphics. VRTX is suitable for both traditional board-based …See details»

Investor Relations | Vertex Pharmaceuticals

2 days ago · [email protected] +1(617)-961-7163. Contacting Vertex's Transfer Agent. Communication regarding transfer requirements, lost certificates and changes of address …See details»

Newsroom | Vertex Pharmaceuticals Newsroom

The Investor Relations website contains information about Vertex Pharmaceuticals Newsroom's business for stockholders, potential investors, and financial analysts.See details»

Vertex Pharmaceuticals | Our Science

We partner with organizations who are driven to innovate together to solve some of science’s most difficult problems. Our partners share our passion and our goals to better the lives of …See details»

Careers | Vertex Pharmaceuticals - vrtx.ca

At Vertex, we have some of the industry's best and brightest people helping us achieve our mission of discovering medicines to help people with serious diseases like cystic fibrosis.See details»

Vertex Pharmaceuticals - Overview, News & Similar companies

Aug 22, 2024 · View Vertex Pharmaceuticals (www.vrtx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»

Press Release - Vertex Pharmaceuticals Newsroom

Jun 21, 2024 · VX-880 has been granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations by the U.S. FDA, and PRIME designation by the European Medicines …See details»

Vertex Reports Fourth Quarter and Full Year 2023 Financial Results ...

Feb 5, 2024 · BOSTON--(BUSINESS WIRE)--Feb. 5, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full …See details»

Press Releases - Vertex Pharmaceuticals

Oct 25, 2024 · BOSTON -- (BUSINESS WIRE)--Oct. 10, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2024 financial results on Monday, …See details»

Vertex Pharmaceuticals | Responsibility | Vertex Volunteers and ...

Vertex Pharmaceuticals provides opportunities for employees to support the causes and organizations that matter to them.See details»

Vertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, …See details»

Vertex Pharmaceutic (VRTX-Q) Stock Price and News

Nov 24, 2022 · Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's …See details»

سری پاور اج VRTX - ویکی‌پدیا، دانشنامهٔ آزاد

"این مقاله در حال ترجمه از ویکی انگلیسی است لطفا حذف نشود.". Dell PowerEdge VRTX خط تولید محصولات سخت افزاری کامپیوتری ازشرکت دل است. [۱] این سیستم، یک شاسی مینی-بلید با سیستم ذخیره سازی داخلی است.VRTX در دو مدل ارائه می شود: یک نسخه 19 ...See details»

linkstock.net © 2022. All rights reserved